| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/21/2011 | US20110177493 Using highly sensitive suspended carbon nanotubes for molecular-level sensing based on optical detection |
| 07/21/2011 | US20110177492 Method of classifying chemically crosslinked cellular samples using mass spectra |
| 07/21/2011 | US20110177339 Fluorescent magnetic nanoparticles and process of preparation |
| 07/21/2011 | US20110177255 Method for producing an aldehyde containing coating |
| 07/21/2011 | US20110177179 Preparation of botanical extracts containing absorbable components using pharmaceutical platform technology |
| 07/21/2011 | US20110177158 Liposomes Capable of Effectively Binding the Beta Amyloid Peptide |
| 07/21/2011 | US20110177156 Sterol-Modified Amphiphilic Lipids |
| 07/21/2011 | US20110177127 Brucella Abortus Proteins and Methods of Use Thereof |
| 07/21/2011 | US20110177107 Predicting and reducing alloimmunogenicity of protein therapeutics |
| 07/21/2011 | US20110177106 Novel Therapeutic Methods for Treating Inflammation and Immune System Disorders |
| 07/21/2011 | US20110177099 Genetic variations associated with drug resistance |
| 07/21/2011 | US20110177094 Ivig modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease |
| 07/21/2011 | US20110177089 Apoptosis inducer |
| 07/21/2011 | US20110177088 Method for Treating and Diagnosing Hematologic Malignancies |
| 07/21/2011 | US20110177087 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse |
| 07/21/2011 | US20110177085 Bitter Taste Receptors |
| 07/21/2011 | US20110177082 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/21/2011 | US20110177080 Novel p2x7 epitopes |
| 07/21/2011 | US20110177079 Cancer-testis antigens |
| 07/21/2011 | US20110177077 Pax 5 monoclonal antibody |
| 07/21/2011 | US20110177066 Prevention and treatment of amyloidogenic diseases |
| 07/21/2011 | US20110177063 Methods for treating colorectal cancer |
| 07/21/2011 | US20110177062 Methods for treating breast cancer |
| 07/21/2011 | US20110177059 Psa and klk2 as therapeutic targets and molecules inhibiting psa and klk2 |
| 07/21/2011 | US20110177058 Methods and compositions for modulating hgf/met |
| 07/21/2011 | US20110177054 Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna |
| 07/21/2011 | US20110177036 Whole blood cultures comprising stimulated immune cells, and use thereof as medicaments |
| 07/21/2011 | US20110177035 Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease |
| 07/21/2011 | US20110177022 Mammalian Cytokines; Related Reagents and Methods |
| 07/21/2011 | US20110176996 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof |
| 07/21/2011 | US20110176995 Diagnosis and treatment of cancer using anti-gpr49 antibody |
| 07/21/2011 | US20110176965 Y-cross mixers and fluid systems including the same |
| 07/21/2011 | US20110176964 Stirring device and an analyzing device |
| 07/21/2011 | US20110176963 Apparatus for analyzing sample |
| 07/21/2011 | US20110174638 Monitoring device and monitoring method |
| 07/21/2011 | US20110174637 Electrode layout for blood test sensor strip |
| 07/21/2011 | US20110174620 Ultra high speed and high sensitivity dna sequencing system and method for same |
| 07/21/2011 | US20110174062 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 07/21/2011 | US20110174053 System and method for stabilizing a sensor |
| 07/21/2011 | US20110173801 Electrochemical Cell and Method of Making an Electrochemical Cell |
| 07/21/2011 | DE10325152B4 Verfahren zur quantitativen Bestimmung einer unbekannten Menge einer Zielmolekülspezies A method for the quantitative determination of an unknown amount of a target molecule species |
| 07/21/2011 | DE102010004917A1 System for sampling and analysis of engine oil for lubricating petrol engine, has feed conduit for feeding sample engine oil to analysis unit, and pump removing engine oil from combustion engine |
| 07/21/2011 | DE102009040261B4 Verfahren zur Überwachung der Wasserqualität an einem Durchflusszähler und Durchflusszähler Procedures for monitoring the water quality at a flow meter and flow meter |
| 07/21/2011 | DE102008003030B4 Verfahren und Mikrofluidvorrichtung zur Parametererfassung Method and apparatus for microfluidic detection parameters |
| 07/21/2011 | DE102007037307B4 System und Verfahren zum Ermitteln des Ethanolgehalts eines Kraftstoffs System and method for determining the ethanol content of a fuel |
| 07/21/2011 | CA2787225A1 Methods for predicting response of triple-negative breast cancer to therapy |
| 07/21/2011 | CA2787201A1 Methods for biomolecule and biomolecule complex (bmc) detection and analysis and the use of such for research and medical diagnosis |
| 07/21/2011 | CA2787048A1 A cut-point in pten protein expression that accurately identifies tumors and is predictive of drug response to a pan-erbb inhibitor |
| 07/21/2011 | CA2787009A1 Surface neutralization of apatite |
| 07/21/2011 | CA2786972A1 Method and apparatus for diagnostic analyses |
| 07/21/2011 | CA2786956A1 Compounds for the treatment of autism |
| 07/21/2011 | CA2786916A1 Multiplex amplification for the detection of nucleic acid variations |
| 07/21/2011 | CA2785552A1 Insulin-like growth factor 1 receptor (igf-1r) protein srm/mrm assay |
| 07/21/2011 | CA2785534A1 Epidermal growth factor receptor (egfr) protein srm/mrm assay |
| 07/21/2011 | CA2785525A1 Insulin receptor substrate 1 (irs1) protein srm/mrm assay |
| 07/21/2011 | CA2785469A1 Secreted protein acidic and rich in cysteine (sparc) protein srm/mrm assay |
| 07/20/2011 | EP2345897A1 Improved method for the detection of polyunsaturated fatty acids |
| 07/20/2011 | EP2345890A2 Pavement material microwave density measurement methods and apparatuses |
| 07/20/2011 | EP2345883A1 Purifying agent for oily liquid containing polybiphenyl chloride |
| 07/20/2011 | EP2345741A1 METHOD FOR MEASURING SURVIVIN mRNA |
| 07/20/2011 | EP2345728A1 Yeast membrane protein expression system and its application in drug screening |
| 07/20/2011 | EP2345724A1 G-CSF analog compositions and methods |
| 07/20/2011 | EP2345722A1 Mutations in the parkin gene, compositions, methods and uses |
| 07/20/2011 | EP2345673A1 Humanized anti-granulocyte MN-3 antibody and uses thereof |
| 07/20/2011 | EP2345672A1 Anti-glycated cd59 antibodies and uses thereof |
| 07/20/2011 | EP2345670A1 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 07/20/2011 | EP2345669A1 NPC1L1 (NPC3) and methods of use thereof |
| 07/20/2011 | EP2345424A1 CD4-specific antibody TRX1 and uses therefor |
| 07/20/2011 | EP2345405A1 Substance for restoring normal co-expression and interaction between LOX and NRAGE proteins |
| 07/20/2011 | EP2345368A1 Sensor strip positioning mechanism |
| 07/20/2011 | EP2345367A1 Electrode layout for blood test sensor strip |
| 07/20/2011 | EP2344938A1 Jet deflection device |
| 07/20/2011 | EP2344892A1 Glucuronidated acetaminophen as a marker of hepatic disorders |
| 07/20/2011 | EP2344891A2 Msp nanopores and related methods |
| 07/20/2011 | EP2344890A2 Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same |
| 07/20/2011 | EP2344889A2 Methods for the selection of therapeutic treatments for cancer |
| 07/20/2011 | EP2344888A2 Imaging techniques using a tridentate ligand |
| 07/20/2011 | EP2344887A1 Biosensor with multi-chamber cartridge |
| 07/20/2011 | EP2344886A1 Ykl-40 as a marker for selection of treatment and monitoring of a disease |
| 07/20/2011 | EP2344885A2 Materials and methods for resolving polyhydric species by electrophoresis |
| 07/20/2011 | EP2344884A1 Semi-sequential assay for detection of an analyte in a sample |
| 07/20/2011 | EP2344883A2 Capturing particles |
| 07/20/2011 | EP2344882A2 Urinary biomarkers for predicting long-term dialysis |
| 07/20/2011 | EP2344881A1 Alzheimer's disease biomarkers |
| 07/20/2011 | EP2344880A1 Methods for identifying stem cells by detecting fluorescence of cells and syncytia |
| 07/20/2011 | EP2344879A2 Detection of vapor phase compounds by changes in physical properties of a liquid crystal |
| 07/20/2011 | EP2344877A1 Molecular probes for imaging of myelin |
| 07/20/2011 | EP2344876A1 Health test for a broad spectrum of health problems |
| 07/20/2011 | EP2344875A1 Correlating push force and stalk vibration to a plant's susceptibility to root lodging |
| 07/20/2011 | EP2344866A2 Plasmonic electricity |
| 07/20/2011 | EP2344865A1 Determination of the salt concentration of an aqueous solution |
| 07/20/2011 | EP2344862A1 An arrangement adapted for spectral analysis of high concentrations of gas |
| 07/20/2011 | EP2344861A1 Dual sample mode spectrophotometer |
| 07/20/2011 | EP2344686A1 Novel triple tag sequences and methods of use thereof |
| 07/20/2011 | EP2344675A1 Gene expression signature of genomic instability in breast cancer |
| 07/20/2011 | EP2344671A1 Biomarkers of mineralocorticoid receptor activation |
| 07/20/2011 | EP2344669A2 Label-free molecule detection and measurement |
| 07/20/2011 | EP2344666A2 Ubiquitin specific proteases responsible for mcl-1 stability and uses thereof |
| 07/20/2011 | EP2344665A1 Use of eef1a as biomarker and a method of screening metap2 inhibitors |
| 07/20/2011 | EP2344623A1 Collection and assay device for biological fluid |